Practice
Featured experience
Nordson $800 million acquisition of Atrion
We are advising Nordson on the acquisition
Gilead Sciences $4.3 billion acquisition of CymaBay Therapeutics
We are advising Gilead Sciences on the acquisition
Owens Corning $3.9 billion acquisition of Masonite International
We are advising Owens Corning on the acquisition
Equinix $2 billion at-the-market offering
We advised Equinix on the offering
LIV Capital Acquisition Corp. II $547 million combination with Covalto
We are advising LIV Capital Acquisition Corp. II, a SPAC, on the transaction
ADC Therapeutics $175 million term loan facility and other financings
We advised the company on the new facility, a $115 million exchange and a $6.25 million share sale
Murphy Oil $200 million tender offers
We advised Murphy Oil on its tender offers for two tranches of notes
Texas Instruments $700 million notes offering
We advised Texas Instruments on its investment-grade debt offering
Morgan Stanley $1 billion preferred stock offering
We advised Morgan Stanley on its SEC-registered offering
NatWest Group and NatWest Markets $7.34 billion cash tender offers
We advised the companies on the transactions
Meta Platforms debut $10 billion senior notes offering
We advised Meta on the investment-grade debt offering
Emerson $3 billion sale of InSinkErator business to Whirlpool
We are advising Emerson on the transaction
Gilead Sciences $405 million acquisition of MiroBio
We are advising Gilead Sciences on the transaction
CSX $2 billion senior notes offering
We advised CSX on the investment-grade debt offering